Health claims here range from hypertrophy training volume debates to chemical exposure fears and cancer-vaccine headlines, often citing WHO or FDA.
330 Health claim verifications avg. score 4.7/10 102 rated true or mostly true 226 rated false or misleading
“Thousands of people have reported severe side effects from semaglutide marketed as Ozempic, including blindness and organ damage.”
There is evidence of a genuine semaglutide-related eye risk, including a very rare blinding condition, but the claim overstates both certainty and scale. The “thousands” figure largely reflects unverified adverse-event reports, not confirmed drug-caused cases. The cited evidence also does not substantiate the separate allegation of organ damage from Ozempic in the way the claim suggests.
“As of May 7, 2026, the case-fatality rate of Hantavirus Pulmonary Syndrome in the United States is about 35%.”
The best U.S. evidence places HPS case-fatality in the mid-to-high 30s, so “about 35%” is broadly accurate. A 1993–2024 summary reports 34.9%, while CDC public-facing materials often round higher, to roughly 38–40%. The claim is reasonable as an approximation, but it understates the higher figure often used by CDC.
“Topical application of lemon juice lightens human skin tone.”
The evidence does not show that raw lemon juice is a reliable way to lighten human skin tone. Laboratory studies on citric acid or lemon extracts suggest possible pigment-related effects, but that is not the same as proven benefit from applying lemon juice to skin. Direct evidence is limited, and real-world use more often raises concerns about irritation, phototoxicity, uneven lightening, or darker post-inflammatory pigmentation.
“Pfizer Inc. listed hantavirus pulmonary syndrome as a potential adverse event of special interest (AESI) or possible side effect in its COVID-19 vaccine safety monitoring documents for the BNT162b2 (Comirnaty) vaccine.”
Pfizer’s safety-monitoring materials did include hantavirus pulmonary syndrome on an AESI-style surveillance list for BNT162b2. That supports the claim’s core factual point. But this does not show Pfizer identified it as a confirmed or likely side effect, and official labeling and regulator product information do not list it as an established adverse reaction.
“In 2026, the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, Anvisa) published Resolution 1,834/2026 ordering the recall and suspension of dozens of Ypê-brand products after an inspection found relevant noncompliance in critical stages of the production process.”
Official records show Anvisa did publish RE 1.834/2026 in May 2026 and ordered the recall and production suspension of listed Ypê products after inspectors found significant failures in critical manufacturing stages. Major Brazilian outlets corroborate that account. The main caveat is that Ypê later obtained a suspensive effect on appeal, pausing enforcement while the case is reviewed.
“Dihydrotestosterone contributes to androgenetic alopecia (pattern hair loss) in humans.”
Evidence from mechanistic studies and human treatment trials supports DHT as a contributor to androgenetic alopecia. Balding scalp shows androgen-related changes consistent with DHT-driven miniaturization, and drugs that lower DHT, such as finasteride and dutasteride, often slow or improve hair loss. The main caveat is that DHT is not the only factor; genetic follicle sensitivity strongly affects who develops pattern hair loss.
“For a non-pregnant adult, drinking one standard glass of red wine per day increases cancer risk compared with drinking no alcohol.”
Available evidence indicates that one daily glass of red wine raises the risk of certain cancers compared with not drinking alcohol, because the carcinogenic agent is ethanol, not the beverage type. Major cancer and public-health agencies state that risk begins at low levels of intake. The main caveat is that wine-specific studies on overall cancer are mixed, and the increase at one drink per day is small in absolute terms and varies by cancer type and sex.
“Researchers estimate that the average person ingests about 5 grams of plastic per week, which is approximately the weight of a credit card.”
The evidence does not show that the average person ingests about 5 grams of plastic per week. The original research estimated a wide range, with 5 grams as an upper-end figure, not the average, and later reviews indicate typical estimates are lower. The “credit card a week” line is a simplified advocacy/media framing that overstates the current scientific picture.
“Humans ingest an estimated 250 grams (about 8.8 ounces) of microplastics per person per year.”
The 250 g/year figure is not supported as a reliable current estimate. It comes from older, assumption-heavy upper-bound modeling that later reviews and WHO-linked literature say likely overstates exposure. More recent assessments report no consensus for 250 g and generally indicate much lower annual intake, often in the tens of grams rather than hundreds.
“In adults under typical conditions, the human brain accounts for about 2% of total body weight but consumes about 20% to 25% of the body's glucose or energy.”
The core claim matches standard physiology references: an adult human brain is about 2% of body weight and uses roughly 20% of the body’s energy, with some sources placing glucose use near 20–25% at rest. The caveat is that these figures are usually stated for resting metabolism, and “glucose” and “energy” are related but not identical measures.
“A resistance-training program consisting only of front squats, Romanian deadlifts, incline bench press, and pull-ups can maintain overall muscle mass (hypertrophy) in healthy adults when performed with adequate training volume and progressive overload.”
A four-lift program like this can likely preserve a large share of muscle mass if effort, volume, and progression are sufficient, but the evidence does not show that it reliably maintains all major muscle groups on its own. The cited research supports compound training and progressive overload in general, not this exact exercise-only template. Muscles such as calves, lateral/rear delts, and some arm regions may need more direct work.
“South African health authorities reported that the Andes strain of hantavirus was identified in two confirmed MV Hondius-linked patients based on testing by the National Institute for Communicable Diseases.”
Official sources support that the MV Hondius outbreak involved Andes hantavirus and that South African authorities reported linked hantavirus cases. But the available primary wording does not clearly show that NICD specifically identified the Andes strain in exactly two confirmed South Africa-linked patients. The claim combines outbreak-level strain confirmation with a later two-patient count in a way that makes the official evidence sound more explicit than it is.
“As of May 7, 2026, the World Health Organization confirmed that a man who traveled to Zurich, Switzerland after disembarking the cruise ship MV Hondius tested positive for hantavirus and was receiving care at a hospital in Zurich, Switzerland.”
Evidence suggests WHO-related communications on May 5-6 referenced a former MV Hondius passenger in Zurich who tested positive and was hospitalized. But Switzerland’s Federal Office of Public Health said on May 7 that it had no notification of such a Zurich case, and WHO’s formal May 4 outbreak notice did not include one. The claim overstates certainty by treating a contested report as cleanly confirmed.
“Two medically evacuated passengers from the cruise ship MV Hondius arrived in the Netherlands for medical treatment after a confirmed hantavirus outbreak occurred on the ship.”
Two evacuated MV Hondius passengers were widely reported as arriving in the Netherlands for treatment, but the claim overstates the medical confirmation. The evidence reviewed does not clearly show that a confirmed hantavirus outbreak had been established on the ship itself before those transfers. Reporting more often referred to suspected cases or limited confirmations tied to individuals, not a definitively confirmed onboard outbreak.
“At Cheddi Jagan International Airport in Guyana, customs officers should not smell-test or touch an unknown powdery substance during baggage screening because synthetic opioids such as fentanyl can be lethal in microdoses.”
Avoiding smell-tests and unnecessary direct handling of unknown powders during baggage screening is sound safety practice, especially to prevent inhalation or transfer to the mouth, nose, or eyes. But the claim’s justification is overstated: major toxicology and public-health bodies say brief incidental skin contact with fentanyl powder is very unlikely to cause overdose, and dermal absorption is generally slow. “Lethal in microdoses” is more applicable to ingestion/injection than casual touch in typical screening conditions.
“Doritos tortilla chips are coated with cheese powder that contains disodium inosinate.”
Reliable ingredient labels show that some Doritos products, including Nacho Cheese variants, contain disodium inosinate in their seasoning. But the claim is phrased as if this applies to Doritos tortilla chips generally, which the evidence does not establish. Different flavors and markets use different formulations, so the blanket statement overstates what the labels show.
“Doritos tortilla chips are sprayed with the food colorings Sunset Yellow FCF (E110, Yellow 6) and Allura Red AC (E129, Red 40), and foods containing these colorings are required to carry warning labels in the European Union.”
The EU warning-label portion is broadly accurate, but the Doritos-specific part is not established by the cited evidence. The record does not reliably show that Doritos generally, or EU-sold Doritos specifically, are "sprayed with" E110 and E129, and the only product-specific source describes lake pigments instead. EU rules also contain limited exceptions, so the labeling statement is not literally universal.
“In India, gallbladder cancer causes nearly 38,000 deaths per year.”
Authoritative cancer estimates do not support a death toll anywhere near 38,000 for gallbladder cancer in India. IARC/WHO GLOBOCAN 2022 puts annual gallbladder cancer deaths at about 16,407, and the higher figure appears to come from conflating gallbladder cancer with broader biliary-tract categories or speculative undercounting. As stated, the claim substantially overstates the burden.
“In India, fewer than 15% of the adult population uses mouthwash (mouthwash penetration is below 15%).”
A firm national estimate that fewer than 15% of Indian adults use mouthwash is not supported by the cited evidence. The only directly measured usage figures come from non-national local surveys (including an urban study reporting much higher current use), and the same study notes a lack of accurate India-wide data while citing only vague “estimates” around 15–20%. Commercial market reports suggesting very low penetration are methodologically opaque and often do not define “penetration.”
“The FDI World Dental Federation confirms that daily oral hygiene routines, including mouthwash use, significantly reduce the incidence of gingivitis, periodontal disease, and dental caries.”
The evidence shows that good daily oral hygiene helps prevent oral disease, but the claim overstates what FDI specifically confirms about mouthwash. FDI guidance treats mouthwash mainly as an adjunct, and the strongest evidence is narrower: some rinses help with gingivitis control and fluoride rinses can reduce caries in certain groups. The record does not clearly show that FDI confirms routine mouthwash use significantly reduces the incidence of periodontal disease.
People also ask
What percentage of adults consume caffeine daily? Is it bad to hold in a sneeze? Does ginger kill worms in sushi?